JPRN-UMIN000027633招募中未知
Randomized phase II study of neoadjuvant chemoradiotherapy (S-1+radiation) for resectable pancreatic cancer with less than 180 degree portal vein abutment - Randomized phase II study of neoadjuvant chemoradiotherapy (S-1+radiation) for resectable pancreatic cancer with less than 180 degree portal vein abutment
agoya University, Graduate School of Medicine0 个研究点目标入组 56 人开始时间: 2017年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who have allergies to S-1 (2) Patients who have active infection (3) Patients with active peptic ulcer (4) Patients with ileus (5) Patients with Grade>=2 diarrhea according to CTCAE v4.0 (6) Patients with uncontrolled ascites or pleural effusion (7) Patients with flucytosine, phenytoin, or warfarin potassium administration (8) Patients with serious comorbid conditions (9) Patients with pregnancy (10) Patients with serious psychiatric diseases (11) Patients who were deemed inappropriate for medical reasons
研究者
相似试验
招募中
1 期
Bintrafusp alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma.retroperitoneal sarcomasMedDRA version: 20.0Level: LLTClassification code 10039494Term: Sarcoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10077289Term: Retroperitoneal sarcomaSystem Organ Class: 100000004864EUCTR2021-001085-37-FRInstitut Bergonié66
已完成
不适用
Randomized phase II study of neoadjuvant chemotherapy with or without letrozole for postmenopausal ER-positive/HER2-negative breast cancersPostmenopausal breast cancerJPRN-UMIN000008416Kobe Breast Cancer Oncology Group70
进行中（未招募）
1 期
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancerMedDRA version: 20.0 Level: LLT Classification code 10029514 Term: Non-small cell lung cancer NOS System Organ Class: 100000004864EUCTR2018-004515-45-ESFundación GECP90
进行中（未招募）
1 期
Study of chemotherapy and immunotherapy for patients with lung cancer bounded in the thorax and potentially resectableon-small cell lung cancer (NSCLC)MedDRA version: 21.1Level: LLTClassification code: 10029514Term: Non-small cell lung cancer NOS Class: 10029104CTIS2024-513731-24-00Fundacion GECP90
已完成
2 期
Randomized Phase II Study of Neoadjuvant Chemotherapy and Trastuzumab (Herceptin) for Operable Breast Cancer with Overexpression of HER2Breast CancerJPRN-UMIN000000651Office for cordination of Herceptin trial100